바이오

Biopharmaceutical

리스트
번호 제목 논문게재일
13 Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degen 15.12
12 A placebo-controlled randomised trial to assess the effect of TGF-ß1-expressing chondrocytes in patients with arthritis of the knee. 15.07
11 A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients. 15.06
10 Genetically modified chondrocytes expressing TGF-β1: a revolutionary treatment for articular cartilage damage? 15.03
9 Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. 15.02
8 Current advances in retroviral gene therapy. 11.06
7 Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). 10.05
6 Continuous transforming growth factor beta1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. 05.02
5 Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor-beta1- producing chondrocytes. 05.10
4 Retroviral gene therapy: safety issues and possible solutions. 05.02
3 Construction of retroviral vectors with enhanced efficiency of transgene expression. 04.11
2 Regeneration of hyaline articular cartilage with irradiated transforming growth factor beta1-producing fibroblasts. 04.06
1 Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts. 01.09
FIRST    1  .   LAST